US Broker Ratings

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Unpacking a 74.33% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) finds itself at a pivotal point, with a potential upside of 74.33% that has captured the attention of investors. As a key player in..

GRAIL, Inc. (GRAL) Stock Analysis: Evaluating the 19.10% Revenue Growth Against Market Challenges

GRAIL, Inc. (GRAL), a leader in the healthcare sector specializing in diagnostics and research, is attracting attention with its innovative approach to cancer detection. Based in Menlo Park, California, GRAIL..

National HealthCare Corporation (NHC) Stock Analysis: A Healthcare Giant with a 25.7% Revenue Growth Story

National HealthCare Corporation (NYSE: NHC) stands as a formidable player in the healthcare sector, focusing primarily on medical care facilities. With a market capitalization of $1.6 billion, NHC operates an..

Janux Therapeutics (JANX) Stock Analysis: Exploring a Potential 236% Upside in Biotech Innovation

Janux Therapeutics, Inc. (NASDAQ: JANX) is making waves in the biotechnology sector, piquing the interest of investors with its innovative approach to cancer treatment and a remarkable potential upside. With..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring a 46% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the dynamic healthcare sector, Schrodinger, Inc. (NASDAQ: SDGR) presents an intriguing proposition. A key player in the health information services industry, Schrodinger stands out with..

HUTCHMED (China) Limited (HCM): Investor Outlook with a Potential Upside of 88.74%

HUTCHMED (China) Limited (HCM), a prominent player in the healthcare sector, is making waves in the drug manufacturing industry with its innovative approach to targeted therapeutics and immunotherapies. With a..

Addus HomeCare Corporation (ADUS) Stock Analysis: Exploring a 22% Upside Potential in the Healthcare Sector

Addus HomeCare Corporation (NASDAQ: ADUS), a leader in the healthcare sector, is capturing the attention of investors with its promising 22.39% upside potential, according to the latest analyst ratings. Boasting..

ImmunityBio, Inc. (IBRX) Investor Outlook: A Promising 326.97% Upside in Biotechnology

ImmunityBio, Inc. (NASDAQ: IBRX) is capturing the attention of investors with its impressive potential upside of 326.97%, as indicated by analyst ratings. This commercial-stage biotechnology company, rooted in the healthcare..

Recursion Pharmaceuticals, Inc. (RXRX): Investor Outlook with a 69.99% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to drug discovery. With a market capitalization of $1.78 billion,..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: 114% Potential Upside Captivates Investor Attention

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical innovator in the healthcare sector, has captured the attention of investors with a remarkable potential upside of 114.76%. As the company continues to..

Structure Therapeutics Inc. (GPCR): Analyst Consensus Highlights a Potential 250% Upside for This Biotech Stock

Structure Therapeutics Inc. (NASDAQ: GPCR), a promising player in the biotechnology sector, is catching the eyes of investors with a substantial market capitalization of $1.25 billion. Specializing in developing novel..

ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: Targeting a 24% Upside with CNS Innovations

ACADIA Pharmaceuticals Inc. (ACAD), a prominent player in the biotechnology sector, is gaining attention for its innovative focus on central nervous system (CNS) disorders and rare diseases. With a market..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Unlocking a 29.98% Potential Upside in Healthcare Innovation

LeMaitre Vascular, Inc. (LMAT), a prominent player in the healthcare sector, specializes in medical instruments and supplies, focusing on innovative solutions for vascular surgery. With a market capitalization of $1.82..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: 36.1% Upside Potential Captivates Investors

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA), a promising player in the healthcare sector, offers a compelling investment opportunity with a potential upside of 36.1%, as suggested by recent analyst ratings. Based..

Galapagos NV (GLPG) Stock Analysis: Navigating the Biotech Landscape with Potential Risks and Rewards

Galapagos NV (NASDAQ: GLPG), a prominent player in the biotechnology sector, is capturing attention with its focus on oncology and immunology. While the company is based in Belgium, its research..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a 121% Potential Upside for Investors

CRISPR Therapeutics AG (NASDAQ: CRSP) is generating significant buzz in the biotechnology sector with its pioneering approach to gene editing. The company, headquartered in Zug, Switzerland, is at the forefront..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: A 26.61% Upside Potential Amidst Healthcare Challenges

In the ever-evolving landscape of healthcare, Pediatrix Medical Group, Inc. (NYSE: MD) stands out as a significant player, providing a wide range of specialized medical services in the United States...

Merus N.V. (MRUS) Stock Analysis: Unveiling a 51% Potential Upside in Biotech Innovation

Merus N.V. (NASDAQ: MRUS), a pivotal player in the biotechnology sector, is capturing the attention of investors with its promising pipeline and impressive market metrics. Headquartered in the Netherlands, this..

Astrana Health Inc. (ASTH) Investor Outlook: Unpacking a 104.49% Potential Upside

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare sector, is capturing the attention of investors with its robust growth metrics and a staggering potential upside of 104.49%...

Arcellx, Inc. (ACLX) Investor Outlook: Biotechnology Stock with 80.10% Potential Upside

For investors seeking opportunities in the biotechnology sector, Arcellx, Inc. (NASDAQ: ACLX) presents a compelling case with a significant potential upside. Headquartered in Redwood City, California, this company operates in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds